Tocilizumab 400mg/20ml solution for infusion vials
NHS hospitals in England used £16,132,155 of indicative cost of Tocilizumab 400mg/20ml solution for infusion vials in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 0.7% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Tocilizumab 400mg/20ml solution for infusion vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Tocilizumab 400mg/20ml solution for infusion vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Leeds Teaching Hpls Nhs Trust | £825,856 |
| Imperial College Healthcare Nhs Trust | £479,232 |
| University College London Foundation Tr | £424,960 |
| Sheffield Teaching Hospitals Nhs Trust | £409,088 |
| Aintree University Hospital Nhs Ft | £401,920 |
| The Royal Wolverhampton Nhs Trust | £401,408 |
| Norfolk & Norwich University Hpl Nhs Trt | £344,064 |
| University Hospital Southampton Nhs Ft | £331,776 |
| Hampshire Hospitals Nhs Foundation Trust | £325,631 |
| East Sussex Healthcare Nhs Trust | £310,272 |
The primary-care picture
Tocilizumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Tocilizumab medicine page.